Soligenix (SNGX) is traded on Nasdaq Capital Markets in USA. It is located in NEW JERSEY, U.S.A and employs 18 people. Soligenix was previously known as Soligenix
and was traded on Nasdaq Capital Markets under the symbol SNGX
. Soligenix is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap
' category with current market capitalization of 13.91 M. Soligenix conducts business under Healthcare
sector and is part of Biotechnology
industry. This company has 8.75 M outstanding shares of which 342.33 K shares are at this time shorted by private and institutional investors with about 10.54 trading days to cover.
SOLIGENIX currently holds about 6.37 M in cash with (6.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check Soligenix Probability Of Bankruptcy